JAIME BETANCOURT: Open Payments
NPI 1013568153 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 75 payments from 24 companies in 2025. Trend: 2023 $1,123 · 2024 $2,225 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 20 | $315 |
| E.R. Squibb & Sons, L.L.C. | 7 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $153 |
| Eisai Inc. | 6 | $118 |
| Merck Sharp & Dohme LLC | 6 | $114 |
| TAIHO ONCOLOGY, INC. | 5 | $92 |
| Janssen Biotech, Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $37 |
Products named: OPDIVO, INJECTAFER, Nubeqa, Lenvima, KEYTRUDA, Enhertu, LONSURF, TECVAYLI.
Industry payments across NY — which companies pay providers there.
